Why Is Abivax Stock Sinking Tuesday?

Abivax SA (NASDAQ:ABVX) stock plunged in Tuesday premarket trading after investors focused on cancer cases reported in the Phase 3 maintenance study of its ulcerative colitis drug obefazimod, overshadowing otherwise strong efficacy results that met the trial’s primary...